Chaudhary Devi Lal University: Admission to BPharma course starts, apply online by August 31st

[ad_1]

Chaudhary Devi Lal University

Chaudhary Devi Lal University

The process of online application for admission to Bachelor of Pharmacy (B.Pharma) degree at Chaudhary Devi Lal University, Sirsa has started on 23rd August. Applicants who would like to be admitted for this can apply online until August 31, 2023.

The spokesman for the university announced that there were a total of 60 seats in BPharma. He shared that admission to this course is based on rank in the online Common Entrance Test (CET) course in Haryana State Technical Education Society’s BPharmacy course. If applicants with CET are not available or if there are still places available after application, admission is based on the 12th grade. He informed that no fee will be charged from online CET Pass students for the admission form. An application fee of Rs. 1000 will be charged from other general category applicants and Rs. 700 for reserved category applicants.

He said admission requirements and more details on admission are available on the university’s website. He said the first list of merits will be issued by the department on September 1. Successful applicants can pay the fees online until midnight on September 4th. He said the second earnings list will be prepared on September 5 and successful applicants have until midnight on September 8 to pay the fees. The details of the vacancies will be uploaded to the university website on September 9th. After that, on September 11th, there will be a physical consultation if there are still places available. Students who are successful in physical counseling have until midnight on September 12 to deposit their dues. He said that even after that, should a seat remain vacant, the seats will be filled on a first-come, first-served basis until September 15.

Also read this – Hisar’s name is associated with the success of Chandrayaan-3: Jindal Stainless’s special type of “alloy” steel in Chandrayaan-3’s engine cover

[ad_2]

Leave a Comment